136 related articles for article (PubMed ID: 11747850)
1. Human immunodeficiency virus-related lymphoma: relation between clinical features and histologic subtypes.
Gabarre J; Raphael M; Lepage E; Martin A; Oksenhendler E; Xerri L; Tulliez M; Audouin J; Costello R; Golfier JB; Schlaifer D; Hequet O; Azar N; Katlama C; Gisselbrecht C;
Am J Med; 2001 Dec; 111(9):704-11. PubMed ID: 11747850
[TBL] [Abstract][Full Text] [Related]
2. Opportunistic infection and immunologic function in patients with human immunodeficiency virus-associated non-Hodgkin's lymphoma treated with chemotherapy.
Sparano JA; Hu X; Wiernik PH; Sarta C; Reddy DM; Hanau L; Henry DH
J Natl Cancer Inst; 1997 Feb; 89(4):301-7. PubMed ID: 9048834
[TBL] [Abstract][Full Text] [Related]
3. Immunophenotypic and genotypic analysis of acquired immunodeficiency syndrome-related non-Hodgkin's lymphomas. Correlation with histologic features in 36 cases. French Study Group of Pathology for HIV-Associated Tumors.
Raphael MM; Audouin J; Lamine M; Delecluse HJ; Vuillaume M; Lenoir GM; Gisselbrecht C; Lennert K; Diebold J
Am J Clin Pathol; 1994 Jun; 101(6):773-82. PubMed ID: 8209868
[TBL] [Abstract][Full Text] [Related]
4. Aggressive lymphomas with renal involvement: a study of 48 patients treated with the LNH-84 and LNH-87 regimens. Groupe d'Etude des Lymphomes de l'Adulte.
Morel P; Dupriez B; Herbrecht R; Bastion Y; Tilly H; Delannoy A; Haioun C; Nouvel C; Bouabdallah K; Baumelou E
Br J Cancer; 1994 Jul; 70(1):154-9. PubMed ID: 7517172
[TBL] [Abstract][Full Text] [Related]
5. Age and serum lactate dehydrogenase level are independent prognostic factors in human immunodeficiency virus-related non-Hodgkin's lymphomas: a single-institute study of 96 patients.
Vaccher E; Tirelli U; Spina M; Talamini R; Errante D; Simonelli C; Carbone A
J Clin Oncol; 1996 Aug; 14(8):2217-23. PubMed ID: 8708710
[TBL] [Abstract][Full Text] [Related]
6. Adult Burkitt's lymphoma in patients with and without human immunodeficiency virus infection in Kenya.
Otieno MW; Remick SC; Whalen C
Int J Cancer; 2001 Jun; 92(5):687-91. PubMed ID: 11340573
[TBL] [Abstract][Full Text] [Related]
7. Human immunodeficiency virus-related lymphoma treatment with intensive combination chemotherapy. French-Italian Cooperative Group.
Gisselbrecht C; Oksenhendler E; Tirelli U; Lepage E; Gabarre J; Farcet JP; Gastaldi R; Coiffier B; Thyss A; Raphael M
Am J Med; 1993 Aug; 95(2):188-96. PubMed ID: 7689296
[TBL] [Abstract][Full Text] [Related]
8. Burkitt-like lymphomas in AIDS patients: characterization within a series of 103 human immunodeficiency virus-associated non-Hodgkin's lymphomas. Burkitt's Lymphoma Study Group.
Davi F; Delecluse HJ; Guiet P; Gabarre J; Fayon A; Gentilhomme O; Felman P; Bayle C; Berger F; Audouin J; Bryon PA; Diebold J; Raphaël M
J Clin Oncol; 1998 Dec; 16(12):3788-95. PubMed ID: 9850023
[TBL] [Abstract][Full Text] [Related]
9. AIDS-related Burkitt's lymphoma versus diffuse large-cell lymphoma in the pre-highly active antiretroviral therapy (HAART) and HAART eras: significant differences in survival with standard chemotherapy.
Lim ST; Karim R; Nathwani BN; Tulpule A; Espina B; Levine AM
J Clin Oncol; 2005 Jul; 23(19):4430-8. PubMed ID: 15883411
[TBL] [Abstract][Full Text] [Related]
10. Burkitt's lymphoma and previous AIDS-defining illnesses are not prognostic factors in AIDS-related non-Hodgkin's lymphoma.
Stebbing J; Mandalia S; Palmieri C; Nelson M; Gazzard B; Bower M
J Clin Oncol; 2005 Nov; 23(33):8538-40; author reply 8540-1. PubMed ID: 16293885
[No Abstract] [Full Text] [Related]
11. Characteristics and outcome of diffuse large B-cell lymphoma in hepatitis C virus-positive patients in LNH 93 and LNH 98 Groupe d'Etude des Lymphomes de l'Adulte programs.
Besson C; Canioni D; Lepage E; Pol S; Morel P; Lederlin P; Van Hoof A; Tilly H; Gaulard P; Coiffier B; Gisselbrecht C; Brousse N; Reyes F; Hermine O;
J Clin Oncol; 2006 Feb; 24(6):953-60. PubMed ID: 16418500
[TBL] [Abstract][Full Text] [Related]
12. Hodgkin's disease associated with human immunodeficiency virus infection. A clinical study of 46 cases. Cooperative Study Group of Malignancies Associated with HIV Infection of Madrid.
Rubio R
Cancer; 1994 May; 73(9):2400-7. PubMed ID: 8168044
[TBL] [Abstract][Full Text] [Related]
13. Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults.
International Collaboration on HIV and Cancer
J Natl Cancer Inst; 2000 Nov; 92(22):1823-30. PubMed ID: 11078759
[TBL] [Abstract][Full Text] [Related]
14. Burkitt's lymphoma in adults with and without human immunodeficiency virus infection: a single-institution clinicopathologic study of 75 patients.
Spina M; Tirelli U; Zagonel V; Gloghini A; Volpe R; Babare R; Abbruzzese L; Talamini R; Vaccher E; Carbone A
Cancer; 1998 Feb; 82(4):766-74. PubMed ID: 9477111
[TBL] [Abstract][Full Text] [Related]
15. [Non-Hodgkin's lymphoma and AIDS: histopathologic features].
Raphael M; Lamine M; Abd Alsamad I; Debré P; Binet JL
Arch Anat Cytol Pathol; 1992; 40(2-3):105-9. PubMed ID: 1449258
[TBL] [Abstract][Full Text] [Related]
16. Is the small non-cleaved-cell lymphoma histologic subtype a poor prognostic factor in adult patients? A case-controlled analysis. The Groupe d'Etude des Lymphomes de l'Adulte.
Diviné M; Lepage E; Brière J; Pautier P; Dupriez B; Lederlin P; Mineur P; Tilly H; Blanc M; Audhuy B; Herbrecht R; Coiffier B; Reyes F
J Clin Oncol; 1996 Jan; 14(1):240-8. PubMed ID: 8558204
[TBL] [Abstract][Full Text] [Related]
17. HIV-associated plasmablastic lymphoma: lessons learned from 112 published cases.
Castillo J; Pantanowitz L; Dezube BJ
Am J Hematol; 2008 Oct; 83(10):804-9. PubMed ID: 18756521
[TBL] [Abstract][Full Text] [Related]
18. Cumulative HIV viremia during highly active antiretroviral therapy is a strong predictor of AIDS-related lymphoma.
Zoufaly A; Stellbrink HJ; Heiden MA; Kollan C; Hoffmann C; van Lunzen J; Hamouda O;
J Infect Dis; 2009 Jul; 200(1):79-87. PubMed ID: 19476437
[TBL] [Abstract][Full Text] [Related]
19. Malignancies in HIV-infected children at Siriraj Hospital.
Sanpakit K; Veerakul G; Kriengsuntornkij W; Chokephaibulkit K; Tanphaichitr VS; Mahasandana C
J Med Assoc Thai; 2002 Aug; 85 Suppl 2():S542-8. PubMed ID: 12403230
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of rasburicase (recombinant urate oxidase) for the prevention and treatment of hyperuricemia during induction chemotherapy of aggressive non-Hodgkin's lymphoma: results of the GRAAL1 (Groupe d'Etude des Lymphomes de l'Adulte Trial on Rasburicase Activity in Adult Lymphoma) study.
Coiffier B; Mounier N; Bologna S; Fermé C; Tilly H; Sonet A; Christian B; Casasnovas O; Jourdan E; Belhadj K; Herbrecht R;
J Clin Oncol; 2003 Dec; 21(23):4402-6. PubMed ID: 14581437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]